← Open Payments lookup

JESSICA ROTH: Open Payments

NPI 1407327224 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,856 in 113 payments from 18 companies in 2025. Trend: 2023 $3,426 · 2024 $4,272 · 2025 $2,856

Food & beverage: $2,721Education: $135
CompanyPaymentsAmount
ABBVIE INC.41$1,026
Janssen Biotech, Inc.18$420
Madrigal Pharmaceuticals9$280
Ipsen Biopharmaceuticals, Inc6$261
Takeda Pharmaceuticals U.S.A., Inc.13$253
Regeneron Healthcare Solutions, Inc.5$101
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$94
Aimmune Therapeutics, Inc.1$89
Phathom Pharmaceuticals, Inc.5$77
Enterra Medical, Inc.1$63

Products named: TREMFYA, RINVOQ, CREON, REZDIFFRA, IQIRVO, SKYRIZI, ENTYVIO, DUPIXENT.

Industry payments across TX — which companies pay providers there.